However, there are opposing reports about the role of FOXO3 expression in cancer, finding that FOXO3 upregulation can act either as a tumor-suppressive or an oncogenic mechanism, depending on the tumor type or specific circumstances [7,10]. The gene discussed is FOXO3; the disease is cancer.